로딩 중…
지수 로딩 중…
Agios Pharmaceuticals, Inc.
AGIO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$34.16+3.26%
2026-06-18
Price Chart
Agios Pharmaceuticals, Inc.-3.77%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.03B |
| Revenue | $66M |
| Net Income | $-423M |
| Total Assets | $1.18B |
| Net Assets | $1.11B |
| Value | |
| P/B | 1.83x |
| P/S | 30.76x |
| FCF Yield | -18.94% |
| Profitability | |
| ROE | -38.10% |
| ROA | -35.66% |
| Op. Margin | -719.97% |
| Revenue Growth | 137.75% |
| Earnings Growth | -161.27% |
| Financial Health | |
| Debt Ratio | 6.84% |
| Total Debt | $36M |
| FCF | $-385M |
| Cash | $114M |
| Current Ratio | 14.19x |
| Performance | |
| 1Y Return | -3.77% |
| 1M Return | 23.19% |
| From 52W High | -25.74% |
| 1Y MDD | -50.89% |
| Trading | |
| Volume | 1,783,524 shares |
| Trading Value | $61M |
| Per Share | |
| EPS | $-7.07 |
| BPS | $20.45 |